Targeted Protein Degradation as an Antiviral Strategy

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

We currently do not have effective vaccines or antiviral drugs for most of the viral diseases that afflict humans.  Antiviral therapies that enable long-term control over human immunodeficiency virus (HIV) infection and cure chronic hepatitis C virus (HCV) have been landmark successes in the treatment of viral infections.  These therapies work through the use of multiple direct-acting antiviral (DAA) drugs that act by potently inhibiting the function of viral proteins, generally enzymes such as viral polymerases and proteases. Narrow spectrum activity (i.e., the “one bug, one drug” problem) and drug resistance are two major challenges for the antivirals field.  This is especially true against viruses with RNA genomes because limited or no proofreading function of the viral polymerase generates tremendous genetic diversity.  There is thus a need for antiviral strategies that make use of alternative targets, mechanisms, and modalities to combat viral diseases and to avoid antiviral resistance.  My group has focused on the discovery and validation of new antiviral targets and strategies. Here I hope to provide to examples of our proof-of-concept work establishing targeted protein degradation as an alternative antiviral strategy.

 

Learning objectives:

1. Understand the mechanism of what a degrader (also known as PROTAC, “degronimid”) is.

2.  Understand how one experimentally determines if a small molecule has a “degrader” mechanism.

3. Explain potential advantages of degraders versus conventional inhibitors as direct-acting antivirals.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
DEC 14, 2021 6:00 AM PST
C.E. CREDITS
DEC 14, 2021 6:00 AM PST
Date: December 14, 2021 Time: 6:00am (PST), 9:00am (EST) Hepatitis E virus (HEV) is a single-stranded positive-sense RNA virus and is a leading cause of acute viral hepatitis worldwide. The...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
Loading Comments...
Show Resources